Page URL:

Gene therapy used in attempt to halt blindness

31 October 2011
Appeared in BioNews 631

A British man has become the first person to receive an advanced gene therapy treatment in a bid to save his sight. Jonathan Wyatt, aged 63, is the first of 12 patients to have the experimental procedure to try and halt the progression of his genetic eye disorder, choroideraemia. While he still has some sight, if left untreated, he would eventually become blind.

If successful, the treatment may soon be in widespread use, and potentially modified to treat other causes of blindness, such as age-related macular degeneration, which affects over 300,000 people in the UK.

Professor Robert MacLaren from the University of Oxford, who is leading the trial, said: 'This disease has been recognised as an incurable form of blindness since it was first described over 100 years ago. I cannot describe the excitement in thinking we have designed a genetic treatment that could potentially stop it in its tracks with one single injection'.

In choroideraemia, eye cells responsible for sensing light – called photoreceptor cells – slowly die off. Vision first becomes affected during childhood and deteriorates over time, eventually leading to complete blindness. The hereditary condition, which affects 1,500 people in the UK, is hereditary and occurs when patients lack a functioning copy of the REP1 gene.

The procedure involves injecting ten billion functioning copies of the REP1 gene directly into the photoreceptor cells in the back of the eye. It is the first time these specific cells have been targeted for gene therapy.

It is hoped the treatment will prevent vision from getting any worse, though it is not expected to reverse damage already done. Professor MacLaren therefore believes that the earlier the therapy is administered the better.

'If this works with Jonathan then we would want to go in and treat patients at a much earlier stage in childhood, effectively where they still have normal vision and can do normal things to prevent them from losing sight', he said.

Professor Sir John Bell, president of the Academy of Medical Sciences, said: 'There is the possibility that you could actually correct the gene defect. Of all the things that are available for this particular set of diseases this is by far the most exciting'.

Gene therapy: New hopes to halt blindness
BBC News |  28 October 2011
Gene therapy used in a bid to save a man's sight
BBC News |  27 October 2011
New gene treatment for blindness trialled in Britain
The Telegraph |  27 October 2011
Scientists use pioneering gene therapy in bid to save man's sight
Daily Mail |  28 October 2011
16 January 2014 - by Siobhan Chan 
Gene therapy for an eye condition called choroideremia is safe and has improved the vision of six patients, says a study in the Lancet...
17 June 2013 - by Rhys Baker 
A 'non-invasive' method for delivering gene therapy into the eye has been developed by US researchers...
13 February 2012 - by Dr Maria Botcharova 
Three women have reported a significant improvement in sight following gene therapy in both their eyes. Initially, they received the therapy in just one eye, but this latest study demonstrates the treatment was also successful in the other...
31 January 2012 - by Rosemary Paxman 
A clinical trial testing the safety of using human embryonic stem cell (hESC) in the treatment of progressive eye conditions has been carried out by researchers in the USA...
26 September 2011 - by Dr Rachael Panizzo 
UK scientists have been granted approval to begin the first clinical trial using embryonic stem cells (ES cells) in Europe, which they hope could lead to an effective treatment for a degenerative eye disease causing blindness...
30 August 2011 - by Rosemary Paxman 
Over a dozen children with 'boy in bubble' syndrome are alive and well, with functioning immune systems, nine years after undergoing gene therapy to correct their disorder, researchers report....
27 June 2011 - by Dr Nadeem Shaikh 
A group of US scientists has successfully used a virus to deliver genes into monkey retinas that could potentially restore damaged photoreceptor cells. The findings could lead to gene therapies being developed to treat blindness and other eye conditions in humans...
20 June 2011 - by Dr Rebecca Robey 
Two clinical trials to test whether embryonic stem cells can treat two incurable eye disorders have been launched in the USA. Twenty-four patients will be treated during the trials at the Jules Stein Eye Institute at the University of California, Los Angeles (UCLA)...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.